Comprehensive Cancer Center of Wake Forest University

Winston-Salem, North Carolina 27157-1082

0 studies enrolling now · 77 studies all time

What they study most

Acinar Cell Adenocarcinoma of the Pancreas, Acute Graft Versus Host Disease, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Undifferentiated Leukemia, Adenocarcinoma of the Gastroesophageal Junction, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)

Studies at this site

• Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients — Running, not enrolling
• Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery — Stopped early
• Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions — Stopped early
• Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis — Completed
• Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer — Completed
• Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer — Stopped early
• CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy — Stopped early
• APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery — Completed
• CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma — Completed
• Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations — Stopped early
• Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer — Completed
• Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer — Completed
• Real-time Location System Feasibility Study — Completed
• CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma — Completed
• Epigenetic and Metabolomic Changes in Childhood Cancer Survivors — Stopped early
• Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3 — Completed
• Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases — Completed
• Attitudes and Knowledge Regarding Clinical Trials in Underserved Populations Receiving Care at the Comprehensive Cancer Center of Wake Forest University — Completed
• CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery — Completed
• CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer — Completed
• MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum — Completed
• Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia — Completed
• Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer — Completed
• Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia — Completed
• Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer — Completed
• Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors — Completed
• Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells — Completed
• Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia — Completed
• Internet-Delivered Positive Affect Program in Managing Emotion in Young Adult Cancer Survivors — Completed
• Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant — Stopped early
• Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer — Completed
• Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas — Completed
• CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery — Completed
• MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment — Completed
• Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy — Completed
• CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed
• Low-Dose Total Lymphoid Irradiation in Treating Patients With Refractory Chronic Graft-versus-Host Disease After Donor Stem Cell Transplant — Stopped early
• Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases — Stopped early
• Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery — Stopped early
• Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery — Completed
• Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies — Completed
• Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract — Withdrawn before enrolling
• CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer — Withdrawn before enrolling
• Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer — Withdrawn before enrolling
• Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy — Withdrawn before enrolling
• Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer — Withdrawn before enrolling
• KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer — Withdrawn before enrolling
• Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy — Stopped early
• High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors — Completed